Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
But the company expects growth to accelerate as a result of this strategic pivot in its weight loss business and executives expect Hims & Hers to hit its target of at least $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030
Semaglutide Semaglutide mimics GLP-1 hormone activity and may help support: Appetite control Reduced cravings Longer feelings of fullness Sustainable weight-loss progress Tirzepatide Tirzepatide works through both GLP-1 and GIP receptor pathways and may help support: Appetite regulation Blood sugar balance Metabolic function Additional flexibility for personalized treatment planning Your provider will review your lab work, medical history, goals, and overall health before recommending the most appropriate option
He Z, Zhu H, Liu J, et al
Heres our straightforward pricing
Cancer is the largest single cause of morbidity incidence in critical illness products
